We all need to think about whether the extreme damage that is being done to people's lives by the reaction to the coronavirus isn't worse than the disease itself.
Read More
Another area dealt with extensively in the MedPAC annual report is Medicare Advantage.
Read More
I am convinced that what we are doing to ourselves in reaction to the corona virus is a grotesque over-reaction which will wreak enormous economic, and health, damage on our citizens. It’s time to fight back by telling politicians to weigh the costs of these measures before they are taken. See #thecureisworsethanthedisease and pass it on.
MedPAC's annual report to Congress includes examination of the effects of hospital consolidation and abuses of the 340B program.
Read More
Research in JAMA finds that orders regarding life-sustaining treatment near the end-of-life are often not followed.
Read More
emid gets an investment from a Blue Cross venture group to support its services to accelerate use of digital technologies by health care and life sciences firms.
https://medcitynews.com/2020/03/leading-digital-transformation-services-firm-emids-receives-investment-from-bluecross-blueshield-venture-partners/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=84573373&_hsenc=p2ANqtz-_MSCadkY9ttki2F80GWn805WfIU5jqTjdi7AKHK8TVS0GuV-zQZVrICX-NcG1dDqBtMq5UsiWFvc2EYlNJPvlOjvwpsjqXPPf5d0DiVyblcdSoFyc&_hsmi=84573373&rf=1A study in JAMA reveals once again the avaricious pricing behavior of drug companies.
Read More
Rivet goes nuts and tells a riveting story to investors to nail down $8.5 million in new financing before it bolts away and screws those investors. The company helps providers track insurance contracts and billings.
https://medcitynews.com/2020/03/startup-raises-8-25m-to-help-physicians-track-payments/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=84573373&_hsenc=p2ANqtz-_MSCadkY9ttki2F80GWn805WfIU5jqTjdi7AKHK8TVS0GuV-zQZVrICX-NcG1dDqBtMq5UsiWFvc2EYlNJPvlOjvwpsjqXPPf5d0DiVyblcdSoFyc&_hsmi=84573373&rf=1The latest Altarum Institute briefs on health spending are released, covering the period through the end of last year.
Read More
Two large benefit consulting and brokerage firms are combining, with AonHewitt set to buy WillisTowersWatson in a $30 billion transaction. The combination should raise serious antitrust concerns.
https://www.benefitnews.com/articles/aon-to-purchase-willis-towers-in-30-billion-deal?position=editorial_2&campaignname=EBN%20Insurance%20Newscast-03092020&utm_source=newsletter&utm_medium=email&utm_campaign=EBN_Daily_Insurance+Newscast%2B%27-%27%2B03092020&bt_ee=%2FcqJmZ03QER3kZdHrizdvnhCtMIidIO44C809z86tAuIzU5KApUIsTcqh0xZow4U&bt_ts=1583791234120About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.